Plexin D1 as a Potential Biomarker inPM/DM
NCT05637931 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 66
Last updated 2022-12-06
Summary
evaluation of level of serum circulating plexin D1 on extacellular vesicles in adult PM/DM patients and juvenile dermatomysitis.
Conditions
- Polymyositis
- Dermatomyositis
Interventions
- DIAGNOSTIC_TEST
-
plexinD1
evaluation of the serum level of plexinD1
Sponsors & Collaborators
-
Assiut University
lead OTHER
Principal Investigators
-
Eman Ahmed Hamed Omran, professor · Assiut University
-
Manal Hassanien, professor · Assiut University
-
Ahmed Abdel Khalek Hafez, lecturer · Assiut University
-
Helal F. Hetta, professor · Assiut University
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-12-25
- Primary Completion
- 2023-12-25
- Completion
- 2024-01-25
More Related Trials
-
The Efficacy and Safety of JAK Inhibitor in the Treatment of Anti-MDA5 Antibody-positive Dermatomyositis Patients
NCT04966884 ·Status: UNKNOWN ·Phase: PHASE4
-
Cellular and Molecular Biomarkers in Patients With Lichen Planus
NCT06451744 ·Status: RECRUITING ·Phase: NA
-
Profibrosing Role of B Lymphocytes in Patients With Systemic Sclerosis.
NCT03559465 ·Status: COMPLETED ·Phase: NA
-
Platelet Gel in Systemic Sclerosis
NCT00463125 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis
NCT05399433 ·Status: RECRUITING ·Phase: NA
-
Treatment Outcome in Early Diffuse Cutaneous Systemic Sclerosis
NCT02339441 ·Status: COMPLETED
-
Clinical Research on Advanced Warning Factors Of Respiratory Injury in Dermatomyositis
NCT04747652 ·Status: UNKNOWN
-
Diabetes and Psoriasis
NCT02366273 ·Status: COMPLETED
-
Coagulopathy of Immunodermatologic Diseases
NCT06037187 ·Status: RECRUITING
-
Early and Long-Term Efficacy and Immune Changes With Dupilumab in Prurigo Nodularis
NCT07276425 ·Status: RECRUITING
-
Optical Coherence Tomography Imaging in Systemic Sclerosis
NCT04532151 ·Status: COMPLETED ·Phase: NA
-
Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
NCT07265999 ·Status: RECRUITING
-
Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles
NCT07298551 ·Status: NOT_YET_RECRUITING
-
Clinico-biological Collection of Autoimmune, Dysimmune or Auto-inflammatory Dermatological Diseases
NCT06387654 ·Status: RECRUITING
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
Effectiveness and Safety of SAR156597 in Treating Diffuse Systemic Sclerosis
NCT02921971 ·Status: COMPLETED ·Phase: PHASE2
-
Role of Circulating Cytotoxic Lymphocytes in Endothelial Cell Injury in Systemic Sclerosis
NCT02636127 ·Status: COMPLETED ·Phase: NA
-
Role of Macrophage Migratory Inhibitory Factor in Systemic Sclerosis
NCT03268330 ·Status: UNKNOWN
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Microvascular and Fibrosis Imaging Study
NCT01758250 ·Status: COMPLETED
-
Evaluation of the Serum Soluble Fractalkine as a Biomarker of Pulmonary Fibrosis in Systemic Sclerosis
NCT03508375 ·Status: UNKNOWN ·Phase: NA
-
Identifying Factors Influencing In-Hospital Relapse in Pemphigus Patients
NCT06167408 ·Status: COMPLETED
-
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
NCT04440592 ·Status: COMPLETED ·Phase: PHASE2
-
Tissue and Serum Level of NLRP1, NLRP3 and Il-18 in Early Stages of mf Patients
NCT06066554 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Analysis of Dermal Fibroblasts and Immune Cells During Systemic Sclerosis
NCT05273138 ·Status: RECRUITING